TICE BCG is a Intravesical Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Bacillus Calmette-guerin Substrain Tice Live Antigen.
| Product ID | 0052-0602_15b47e92-12ad-4829-a163-21e527009a77 |
| NDC | 0052-0602 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TICE BCG |
| Generic Name | Bacillus Calmette-guerin |
| Dosage Form | Powder, For Suspension |
| Route of Administration | INTRAVESICAL |
| Marketing Start Date | 1990-08-24 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102821 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN |
| Active Ingredient Strength | 50 mg/50mL |
| Pharm Classes | Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [CS],BCG Vaccine [CS],Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC],Increased Macrophage Proliferation [PE],Increased Immunologically Active Molecule Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1990-08-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102821 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1990-08-24 |
| Marketing Category | BLA |
| Application Number | BLA102821 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-11-21 |
| Ingredient | Strength |
|---|---|
| BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | 50 mg/50mL |
| SPL SET ID: | c9b74876-e665-442b-87ad-b7333bc9a67a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |